:::

詳目顯示

回上一頁
題名:藥物基因體學之政策與法律議題分析
書刊名:法律與生命科學
作者:何建志 引用關係
出版日期:2008
卷期:4
頁次:頁1-17
主題關鍵詞:藥物基因體學藥物遺傳學
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(3) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:1
  • 共同引用共同引用:16
  • 點閱點閱:1
期刊論文
1.Green, Ronald M.、Thomas, A. Mathew(1998)。DNA: Five Distinguishing Features for policy Analysis。Harvard Journal of Law & Technology,11(3),571-591。  new window
2.Chung, Wen-Hung、Hung, Shuen-Iu、Hong, Hong-Shang、Hsih, Mo-Song、Yang, Li-Cheng、Ho, Hsin-Chun、Wu, Jer-Yuarn、Chen, Yuan-Tsong(2004)。Medical Genetics: A Marker for Stevens-Johnson Syndrome。Nature,428(6982)。  new window
3.Robertson, John A.、Brody, Baruch、Buchanan, Allen、Kahn, Jeffrey、McPherson, Elizabeth(2002)。Pharmacogenetic Challenges for the Health Care System。Health Affairs,21(4),155-167。  new window
4.Lindpaintner, Klaus(2003)。Pharmacogenetics and Pharmacogenomics in Drug Discovery and Development: An Overview。Clinical Chemistry & Laboratory Medicine,41(4),398-410。  new window
5.Johnson, Julie A.(2003)。Pharmacogenetics: Potential for Individualized Drug Therapy Through Genetics。Trends in Genetics,19(11),660-666。  new window
6.Phillips, Kathryn A.、Veenstra, D. L.、Oren, E.、Lee, J. K.、Sadee, W.(2001)。Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review。JAMA,286(18),2270-2279。  new window
7.Sachidanandam, Ravi、Weissmann, David、Schmidt, Steven C.、Kakol, Jerzy M.、Stein, Lincoln D.、Marth, Gabor、Sherry, Stephen T.、Mullikin, James C.、Mortimore, Beverley J.、Willey, David L.(2001)。A Map of Human Genome Sequence Variation Containing 1.42 Million Single Nucleotide Polymorphisms。Nature,409,928-933。  new window
8.Festin, Patricia M.(2005)。The Regulatory, Economic, and Privacy Implications of Pharmacogenomics。Virginia Journal of Law & Technology,10(2)。  new window
9.Buchanan, Allen、Califano, Andrea、Kahn, Jeffrey、McPherson, Elizabeth、Robertson, John、Brody, Baruch(2002)。Pharmacogenetics: Ethical Issues and Policy Options。Kennedy Institute of Ethics Journal,12(1),1-15。  new window
10.Lipton, P.(2003)。Pharmacogenetics: the Ethical Issues。The Pharmacogenomics Journal,3,14-16。  new window
11.Mandry, Tilo(2004)。Legal Implications of Pharmacogenomics Regarding Drug Trials, Drug Labeling, and Genetic Testing for Drug Prescription: An International Approach。Food and Drug Law Journal,59(4),519-535。  new window
12.Lesko, L. J.、Woodcock, J.(2002)。Pharmacogenomic-Guided Drug Development: Regulatory Perspective。The Pharmacogenomics Journal,2,20-24。  new window
13.Evans, Barbara J.(2006)。What Will It Take to Reap the Clinical Benefits of Pharmacogenomics?。Food and Drug Law Journal,61(4),753-794。  new window
14.McCarthy, Alun(2000)。Pharmacogenetics: Implications for Drug Development, Patients and Society。New Genetics and Society,19(2),135-143。  new window
15.Robertson, John A.(2001)。Consent and Privacy in Pharmacogenetic Testing。Nature Genetics,28(3),207-209。  new window
16.(2003)。Pharmacogenetics to come。Nature,425,749。  new window
會議論文
1.林子儀(20030000)。基因資訊與基因隱私權--從保障隱私權的觀點論基因資訊的利用與法的規制。基因技術挑戰與法律回應:基因科技與法律研討會。臺北:學林文化。239-296。  延伸查詢new window
學位論文
1.黃崇呈(2006)。使用仿單核准適應症外處方之責任(碩士論文)。國立清華大學。  延伸查詢new window
圖書
1.何建志(2003)。基因歧視與法律對策之研究。台北:元照。new window  延伸查詢new window
2.Holtzman, Neil A.、Watson, Michael S.(1998)。Promoting Save and Effective Genetic Testing in the United States: Final Report of the Task Force on Genetic Testing。Baltimore, Maryland:Johns Hopkins University Press。  new window
3.Nuffield Council on Bioethics(2003)。Pharmacogenetics: Ethical Issues。  new window
4.The Secretary's Advisory Committee on Genetics, Health, and Society(2007)。Realizing the Promise of Pharmacogenomics: Opportunities and Challenges。  new window
5.Advisory Committee on Genetic Testing(1998)。Report on Genetic Testing for Late Onset Disorders。  new window
其他
1.Food and Drug Administration(2005)。Guidance for Industry: Pharmacogenomic Data Submissions,http://www.fda.gov/cder/genomics/regulatory.htm, 。  new window
2.Health Canada(2007)。Submission of Pharmacogenomic Information,http://www.hc-sc.gc.ca/dhp-mps/brgtherap/applic-demande/guides/pharmaco/pharmaco_guid_ld_2007-02_e.html。  new window
3.Submissions and Labels in Regulatory Pharmacogenomics,http://www.fda.gov/cder/genomics/PGCaseStudies.pdf。  new window
圖書論文
1.Murray, Thomas H.(1997)。Genetic Exceptionalism and "Future Diaries": Is Genetic Information Different from Other Medical Information?。Genetic Secrets: Protecting Privacy and Confidentiality in the Genetic Era。New Haven:Yale University Press。  new window
2.Holm, Søren(1999)。There Is Nothing Special About Genetic Information。Genetic Information: Acquisition, Access, and Control。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
:::
QR Code
QRCODE